Biocatalysts plan £6m investment following acquisition

Specialist biotechnology company Biocatalysts, which was recently acquired by Brain AG, is investing £6m in expanding its manufacturing capacity.

Insider media reports the company, which manufactures enzymes, has extended its existing facilities in Nantgarw by 11,000 sq ft and now plans to fit the space out with new software controlled equipment, including a 10,000L fermenter and downstream processing machinery. The new production area will also give the company space to expand its capacity further in future.

Daren Bryce, commercial director at Biocatalysts, said “This represents a very exciting time in the speciality enzyme field. The unique breadth of offering that Biocatalysts has, from discovery right through to large scale production, will allow previously in-accessible novel enzymes at commercial scale to our customers.”

Free WordPress Themes, Free Android Games